Facebook
Twitter
Telegram
Report an ErrorMarinus Pharmaceuticals Financial Statements 2011-2024 | MRNS
Annual Financial Statements Marinus Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
497 M | 286 M | 436 M | 339 M | 114 M | 130 M | 177 M | 23.2 M | 86.1 M | 68.3 M | 124 M | 65.4 M | - |
Shares |
53.7 M | 39.1 M | 36.7 M | 27.3 M | 13.6 M | 10.2 M | 5.89 M | 4.87 M | 3.73 M | 1.54 M | 1.85 M | 2.02 M | - |
Historical Prices |
9.24 | 7.31 | 11.9 | 12.2 | 8.64 | 11.5 | 32.6 | 4.04 | 30.6 | 42.3 | - | - | - |
Net Income |
-141 M | -19.8 M | -98.8 M | -67.5 M | -54.1 M | -36.7 M | -18.9 M | -28.6 M | -24.8 M | -10.8 M | -5.27 M | -1.41 M | - |
Revenue |
31 M | 25.5 M | 15.3 M | 1.72 M | - | - | - | - | - | - | - | 100 K | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-131 M | -113 M | -96.9 M | -67.9 M | -54.4 M | -37.2 M | -19 M | -28.2 M | -24.4 M | -11.9 M | -5.38 M | - | - |
Interest Expense |
16.9 M | 10.7 M | 2.58 M | -37 K | -53 K | -1 K | 159 K | 464 K | 475 K | 117 K | 91 K | - | - |
EBITDA |
-131 M | -112 M | -96.6 M | -67.6 M | -54.1 M | -37.1 M | -18.9 M | -28.2 M | -24.4 M | -11.9 M | -5.17 M | -1.41 M | - |
Operating Expenses |
- | - | - | 69.7 M | 54.4 M | 37.2 M | 19 M | 28.2 M | 24.4 M | 11.9 M | - | - | - |
General and Administrative Expenses |
61.2 M | 56.8 M | 37.3 M | 18.5 M | 11.5 M | 8.78 M | 6.67 M | 6.24 M | 5.52 M | 3.23 M | 1.23 M | 685 K | - |
All numbers in USD currency
Quarterly Income Statement Marinus Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
56.9 M | 54.6 M | 53.9 M | 52.6 M | 51.8 M | 49.6 M | 37.2 M | 37.2 M | 36.9 M | 36.8 M | 36.7 M | 36.7 M | 36.6 M | 36.6 M | 30.6 M | 24.9 M | 21.7 M | 21.6 M | 13.1 M | 52.5 M | 52.5 M | 52.5 M | 40.4 M | 40.4 M | 40.4 M | 40.5 M | 28.7 M | 22 M | 20.6 M | 19.7 M | 19.5 M | 19.5 M | 19.5 M | 19.4 M | 12.3 M | 14.2 M | 14.1 M | 14 M | 9.45 M | 554 K | 467 K | 465 K | 492 K | 463 K | - | - | - | - | - | - | - | - | - |
Net Income |
-38.7 M | - | -33 M | -31.9 M | -34.7 M | - | 73.3 M | -39.4 M | -19.4 M | - | -19.5 M | -23.8 M | -27.1 M | - | -15.7 M | -15.7 M | -18.7 M | -15.4 M | -13.8 M | -12.4 M | -12.5 M | -10.1 M | -11.1 M | -9.5 M | -6 M | -4.74 M | -4.17 M | -4.55 M | -5.44 M | -6.01 M | -6.46 M | -8.95 M | -7.22 M | -7.61 M | -4.96 M | -5.27 M | -7.01 M | -3.61 M | -1.67 M | -3.32 M | -2.24 M | -1.39 M | -1.22 M | -1.68 M | -970 K | - | - | - | - | - | - | - | - |
Revenue |
7.68 M | - | 7.34 M | 6.08 M | 10.4 M | - | 2.34 M | 1.79 M | 14.2 M | - | 10.1 M | 1.9 M | 1.81 M | - | 171 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | 1.17 M | 1.17 M | - | 1.48 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-35.8 M | - | -31.6 M | -31.4 M | -33 M | - | -30.1 M | -36.8 M | -16.7 M | - | -19.2 M | -23.5 M | -27.2 M | - | -15.7 M | -15.9 M | -18.9 M | - | -13.9 M | -12.5 M | -12.5 M | - | -11.2 M | -9.57 M | -6.11 M | - | -4.21 M | -4.51 M | -5.38 M | - | -6.37 M | -8.84 M | -7.1 M | - | -4.85 M | -5.17 M | -6.92 M | - | -2.44 M | -3.26 M | -2.66 M | - | -1.32 M | -1.64 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
4.35 M | - | 4.24 M | 4.21 M | 4.15 M | - | 2.63 M | 2.66 M | 1.69 M | - | 678 K | 351 K | -4 K | - | -39 K | -5 K | -40 K | - | -42 K | -1 K | -40 K | - | - | 1 K | -1 K | - | 3 K | 72 K | 84 K | - | 118 K | 124 K | 124 K | - | 121 K | 117 K | 116 K | - | 29 K | 29 K | - | - | 90.6 K | 44.5 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-35.7 M | - | - | - | -32.8 M | - | -29.8 M | -36.6 M | -16.6 M | - | -18.9 M | -23.3 M | -27.1 M | - | -15.5 M | -15.7 M | -18.8 M | - | -13.7 M | -12.4 M | -12.5 M | - | -11.1 M | -9.5 M | -6.08 M | - | -4.18 M | -4.49 M | -5.38 M | - | -6.35 M | -8.84 M | -7.1 M | - | -4.84 M | -5.16 M | -6.91 M | - | -2.43 M | -3.26 M | -2.66 M | - | -1.32 M | -1.64 M | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
18.6 M | - | 14.9 M | 15.7 M | 15.2 M | - | 13.4 M | 17.1 M | 11.7 M | - | 9.45 M | 6.83 M | 10.4 M | - | 4.56 M | 4.13 M | 3.85 M | 2.96 M | 2.33 M | 2.5 M | 3.67 M | 2.19 M | 2.07 M | 2.34 M | 2.19 M | 1.59 M | 1.57 M | 1.69 M | 1.81 M | 1.52 M | 1.53 M | 1.59 M | 1.6 M | 1.44 M | 1.38 M | 1.26 M | 1.45 M | 1.39 M | 868 K | 458 K | 517 K | 422 K | 313 K | 314 K | 180 K | - | - | - | - | - | - | - | - |
All numbers in USD currency